Cencora (COR) Cost of Revenue (2009 - 2026)

Cencora (COR) reported Cost of Revenue of $74.8 billion for Q1 2026, up 3.28% on a YoY basis from $72.4 billion in Q1 2025, and down 9.77% quarter-over-quarter from $82.9 billion in Q4 2025.

Cencora (COR) Cost of Revenue (2009 - 2026) Analysis & Trends

Cencora has reported Cost of Revenue for 18 years, with the latest figure at $74.8 billion in Q1 2026.

  • For the quarter ending Q1 2026, Cost of Revenue rose 3.28% year-over-year to $74.8 billion; the trailing twelve-month figure through Mar 2026 stood at $316.2 billion (up 5.49% YoY), and the FY2025 full-year result was $309.9 billion, up 9.08% from the prior year.
  • Cost of Revenue for Q1 2026 stood at $74.8 billion, down from $82.9 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $82.9 billion in Q4 2025, with the low at $55.5 billion in Q1 2022.
  • Historically, Cost of Revenue has averaged $69.3 billion across 5 years, with a median of $69.8 billion in 2023.
  • Annual changes were most pronounced in 2022 — Cost of Revenue rose 16.51% — and 2026, when it rose 3.28%.
  • Cencora's Cost of Revenue stood at $60.7 billion in 2022, then climbed by 14.96% to $69.8 billion in 2023, then grew by 13.1% to $78.9 billion in 2024, then grew by 4.98% to $82.9 billion in 2025, then fell by 9.77% to $74.8 billion in 2026.
  • The last three Cost of Revenue figures came in at $74.8 billion (Q1 2026), $82.9 billion (Q4 2025), and $80.8 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn 92.25 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 74.77 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn 58.44 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn 2.30 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn 315.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn 9.67 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn 379.70 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn 19,352.00
10 Cellyan Biotechnology 5.69 -2.48 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 74.77 Bn
Mar 31, 2026 74.77 Bn
Dec 31, 2025 82.86 Bn
Dec 31, 2025 82.86 Bn
Sep 30, 2025 80.77 Bn
Sep 30, 2025 80.77 Bn
Jun 30, 2025 77.76 Bn
Jun 30, 2025 77.76 Bn
Mar 31, 2025 72.39 Bn
Mar 31, 2025 72.39 Bn
Dec 31, 2024 78.93 Bn
Dec 31, 2024 78.93 Bn
Sep 30, 2024 76.56 Bn
Sep 30, 2024 76.56 Bn
Jun 30, 2024 71.83 Bn
Jun 30, 2024 71.83 Bn
Mar 31, 2024 65.88 Bn
Mar 31, 2024 65.88 Bn
Dec 31, 2023 69.78 Bn
Dec 31, 2023 69.78 Bn